J.P. Morgan reported in May that the first quarter of 2025 and fourth quarter of 2024 showed the highest acquisition activity ...

With a market cap of $19.6 billion, Zimmer Biomet Holdings, Inc. (ZBH) is a global medical technology company specializing in ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

This past summer, junior Natalie Hofer explored the business side of the healthcare industry with her internship at Zimmer Biomet, a medical technology company at the forefront of healthcare ...

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is among the undervalued wide moat stocks to buy now. As disclosed with the SEC, ...

LONDON, GREATER LONDON, UNITED KINGDOM, September 10, 2025 /EINPresswire.com/ -- How Much Is The Cementless Total Knee Arthroplasty Market Worth? The cementless total knee arthroplasty market size has ...

Zimmer Biomet Holdings, Inc. ( NYSE: ZBH) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 8:30 AM EDT ...

While Zimmer has been able to maintain the largest market share over the past decade, competition in the knee reconstruction space is no longer limited to pricing or incremental design improvements.

A knee-replacement implant, used in thousands of UK operations, was known to have a concerning failure rate eight years before it was finally withdrawn, the BBC has discovered.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q2 2025 Earnings Call Transcript August 7, 2025 Zimmer Biomet Holdings, Inc. beats earnings expectations. Reported EPS is $2.07, expectations were $1.98.

Aug 7 (Reuters) - Medical device maker Zimmer Biomet Holdings (ZBH.N), opens new tab raised its annual adjusted profit forecast on Thursday as it anticipates lower-than-expected tariff impacts, ...

Zimmer Biomet Q2 EPS rises 3% to $2.07, beating the $1.99 estimate; sales reaches $2.08 billion, topping the consensus. 2025 EPS guidance raises to $8.10–$8.30 vs. $7.90–$8.10 prior; revenue growth ...